Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Skye Bioscience (SKYE)
NASDAQ:SKYE
Holding SKYE?
Track your performance easily
SKYE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.44 - $19.41
Previous Close$5.8
Volume124.83K
Average Volume (3M)250.13K
Market Cap
$175.96M
Enterprise Value$106.91M
Total Cash (Recent Filing)$74.12M
Total Debt (Recent Filing)$5.07M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Aug 09, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.91
Shares Outstanding30,338,290
10 Day Avg. Volume169,049
30 Day Avg. Volume250,134
Standard Deviation0.47
R-Squared0.04
Alpha0.00924
Financial Highlights & Ratios
Price to Book (P/B)2.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.42
Forecast
1Y Price Target
$17.60Price Target Upside233.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Skye Bioscience News
PremiumCompany Announcements
Skye Bioscience Welcomes New CMO Dr. Puneet Arora
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SKYE FAQ
What was Skye Bioscience’s price range in the past 12 months?
Skye Bioscience lowest stock price was $1.44 and its highest was $19.41 in the past 12 months.
What is Skye Bioscience’s market cap?
Currently, no data Available
When is Skye Bioscience’s upcoming earnings report date?
Skye Bioscience’s upcoming earnings report date is Aug 09, 2024 which is 42 days ago.
How were Skye Bioscience’s earnings last quarter?
Currently, no data Available
Is Skye Bioscience overvalued?
According to Wall Street analysts Skye Bioscience’s price is currently Undervalued.
Does Skye Bioscience pay dividends?
Skye Bioscience does not currently pay dividends.
What is Skye Bioscience’s EPS estimate?
Skye Bioscience’s EPS estimate is -$0.2.
How many shares outstanding does Skye Bioscience have?
Skye Bioscience has 30,338,290 shares outstanding.
What happened to Skye Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Skye Bioscience?
Among the largest hedge funds holding Skye Bioscience’s share is Versant Venture Management, LLC. It holds Skye Bioscience’s shares valued at 16M.
---
Skye Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.60 (233.33% Upside)
$17.60 (233.33% Upside)
Blogger Sentiment
Bullish
SKYE Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 16.8%
Last 30 Days ▲ 22.0%
Last 30 Days ▲ 22.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
208.51%
12-Months-Change
Fundamentals
Return on Equity
-130.08%
Trailing 12-Months
Asset Growth
3802.67%
Trailing 12-Months
Company Description
Skye Bioscience
Emerald Bioscience, Inc. engages on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. The company was founded on March 16, 2011 and is headquartered in Long Beach, CA.
---
SKYE Stock 12 Month Forecast
Average Price Target
$17.60
▲(233.33% Upside)
Technical Analysis
Enveric Biosciences
―
Cyclacel Pharmaceuticals
―
Actinium Pharmaceuticals
―
Kura Oncology
―
Best Analysts Covering SKYE
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-8.58%
reiterated a buy rating 11 days ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -8.58% per trade.
---